American Century Companies Inc. Sells 19,240 Shares of Medifast Inc $MED

Key Points

• American Century Companies Inc. has reduced its stake in MEDIFAST INC by 7.9%, now holding approximately 2.05% of the company worth $3,032,000 after selling 19,240 shares.
• Several hedge funds have altered their positions in MEDIFAST, with Charles Schwab Investment Management Inc. increasing its stake by 132.7%, now owning 265,572 shares valued at $3,580,000.
• MEDIFAST reported earnings of $0.04 per share, surpassing estimates, and achieved a revenue of $105.56 million for the quarter, which exceeded consensus expectations.

American Century Companies Inc. lowered its stake in shares of Medifast Inc (NYSE:MED - Free Report) by 7.9% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 224,945 shares of the specialty retailer's stock after selling 19,240 shares during the period. American Century Companies Inc. owned approximately 2.05% of Medifast worth $3,032,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also recently made changes to their positions in MED. Charles Schwab Investment Management Inc. boosted its stake in shares of Medifast by 132.7% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 265,572 shares of the specialty retailer's stock valued at $3,580,000 after purchasing an additional 151,434 shares in the last quarter. Two Sigma Advisers LP increased its position in Medifast by 86.0% during the 4th quarter. Two Sigma Advisers LP now owns 216,000 shares of the specialty retailer's stock valued at $3,806,000 after purchasing an additional 99,900 shares during the period. Peapod Lane Capital LLC purchased a new stake in Medifast during the 1st quarter worth approximately $933,000. Nuveen LLC acquired a new position in Medifast during the first quarter valued at $407,000. Finally, Two Sigma Investments LP raised its position in shares of Medifast by 11.4% in the fourth quarter. Two Sigma Investments LP now owns 232,069 shares of the specialty retailer's stock valued at $4,089,000 after buying an additional 23,822 shares during the last quarter. Institutional investors and hedge funds own 95.51% of the company's stock.

Medifast Stock Down 0.6%

Medifast stock traded down $0.09 during mid-day trading on Friday, reaching $13.77. 63,625 shares of the company's stock were exchanged, compared to its average volume of 222,887. The company has a fifty day moving average of $13.98 and a 200-day moving average of $13.65. The company has a market cap of $151.28 million, a P/E ratio of 43.02 and a beta of 0.82. Medifast Inc has a twelve month low of $11.57 and a twelve month high of $21.98.

Medifast (NYSE:MED - Get Free Report) last posted its earnings results on Monday, August 4th. The specialty retailer reported $0.04 earnings per share for the quarter, beating the consensus estimate of ($0.22) by $0.26. The firm had revenue of $105.56 million during the quarter, compared to the consensus estimate of $96.10 million. Medifast had a net margin of 0.76% and a return on equity of 2.00%. Medifast has set its Q3 2025 guidance at -0.600-0.00 EPS. Equities research analysts expect that Medifast Inc will post 0.51 earnings per share for the current fiscal year.

Medifast Profile

Medifast, Inc, through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names.